PTPA and acute myeloid leukemia: In AML models, CK2 genetic silencing and pharmacological inhibition did not result in exclusion of SET from the cytosol of AML cells, indicating that targeting a single kinase might not be sufficient to release PP2A from SET inhibition [99].